Skip to main content

TGF-β Receptors and Signal Transduction

  • Conference paper
Book cover Bone Marrow Transplantation
  • 84 Accesses

Summary

Transforming growth factor-β (TGF-β) is a family of 25-kDa dimeric proteins that regulate the cellular growth and differentiation, the formation of extracellular matrix, and the immune function. TGF-βs belong to a larger family of structurally related proteins known as the TGF-β superfamily, which includes activins and bone morphogenetic proteins. TGF-β exerts the effects through binding to type I (TβR-I; 53 kDa) and type II (TβR-II; 75 kDa) serine/threonine kinase receptors. Overall structures of TβR-I and TβR-II are similar to each other. Preceding the kinase domain of TβR-I, there is a region termed the GS domain, which is conserved in type I receptors, but not in type II receptors. After ligand binding, TβR-I and TβR-II form a heteromeric receptor complex, which is most likely a heterotetramer composed of two molecules each of TβR-I and TβR-II. TβR-II transphosphorylates the GS domain of TβR-I, which then activates the TβR-I kinase and transduces signals. By yeast two-hybrid system, several proteins which interact with type I or type II receptors, and possibly transduce the signals for TGF-p, have been isolated. Mutations in the TβR-II gene have been identified in several carcinoma cells, which suggests that loss of the TβR-II protein is one of the mechanisms by which cancer cells acquire resistance to the growth inhibitory activity of TGF-β.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Miyazono K, ten Dijke P, Ichijo H, Heldin C-H (1994) Receptors for transforming growth factor-β. Adv Immunol 55: 181–220

    Article  PubMed  CAS  Google Scholar 

  2. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133–146

    Article  PubMed  CAS  Google Scholar 

  3. Roberts AB, Sporn MB (1990) The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors, part I. Springer-Verlag, Berlin, pp 419–472

    Google Scholar 

  4. Sporn MB, Roberts AB (1992) Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119: 1017–1021

    Article  PubMed  CAS  Google Scholar 

  5. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T (1992) Targeted disruption of the mouse transforming growth factor-βl gene results in multifocal inflammatory disease. Nature 359: 693–699

    Article  PubMed  CAS  Google Scholar 

  6. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor βl null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770–774

    Article  PubMed  CAS  Google Scholar 

  7. Mathews LS (1994) Activin receptors and cellular signaling by the receptor serine kinase family. Endocrine Rev 15: 310–325

    CAS  Google Scholar 

  8. Murata M, Eto Y, Shibai H, Sakai M, Muramatsu M (1988) Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin βA chain. Proc Natl Acad Sci USA 85: 2434–2438

    Article  PubMed  CAS  Google Scholar 

  9. Wozney JM (1989) Bone morphogenetic proteins. Prog Growth Factor Res 1: 267–280

    Article  PubMed  CAS  Google Scholar 

  10. Reddi AH (1992) Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 4: 850–855

    Article  PubMed  CAS  Google Scholar 

  11. Reddi AH (1994) Bone and cartilage differentiation. Curr Opin Genet Develop 4: 737–744

    Article  CAS  Google Scholar 

  12. Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9: 2105–2116

    Article  PubMed  CAS  Google Scholar 

  13. Miyazono K, ten Dijke P, Yamashita H, Heldin C-H (1994) Signal transduction via serine/threonine kinase receptors. Seminars Cell Biol 5: 389–398

    Article  CAS  Google Scholar 

  14. Massagué J, Attisano L, Wrana JL (1994) The TGF-β family and its composite receptors. Trends Cell Biol 4: 172–178

    Article  PubMed  Google Scholar 

  15. Derynck R (1994) TGF-β-receptor-mediated signaling. Trends Biochem Sci 19: 548–553

    Article  PubMed  CAS  Google Scholar 

  16. ten Dijke P, Miyaono K, Heldin C-H (1996) Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol (in press)

    Google Scholar 

  17. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin C-H, Miyazono K (1993) Activin receptor-like kinases; A novel subclass of cell surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879–2887

    PubMed  CAS  Google Scholar 

  18. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, Miyazono K (1993) Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75: 781–792

    Article  Google Scholar 

  19. ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin C-H (1994) Characterization of type I receptors for transforming growth factor-13 and activin. Science 264: 101–104

    Article  PubMed  Google Scholar 

  20. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785

    Article  PubMed  CAS  Google Scholar 

  21. Wrana JL, Attisano L, Cârcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massagué J (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014

    Article  PubMed  CAS  Google Scholar 

  22. Letsou A, Arora K, Wrana JL, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J, O’Connor MB (1995) Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGFβ receptor family. Cell 80: 899–908

    Article  PubMed  CAS  Google Scholar 

  23. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin C-H, Miyazono K (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269: 16985–16988

    PubMed  Google Scholar 

  24. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, Chen G-X, Wrana JL, Massagué J, Rosenbaum JS (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14: 5961–5974

    PubMed  CAS  Google Scholar 

  25. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin C-H, Miyazono K (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92: 7632–7636

    Article  PubMed  CAS  Google Scholar 

  26. Liu F, Ventura F, Doody J, Massagué J (1995) Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15: 3479–3486

    PubMed  CAS  Google Scholar 

  27. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Hanse Wolsing D, Rosenbaum JS (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptor. J Biol Chem 270: 22522–22526

    Article  PubMed  CAS  Google Scholar 

  28. WranaJL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370: 341–347

    Article  PubMed  CAS  Google Scholar 

  29. Henis YI, Moustakas A, Lin HY, Lodish HF (1994) The types II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol 126: 139–154

    Article  PubMed  CAS  Google Scholar 

  30. Chen R-H, Derynck R (1994) Homomeric interactions between type II transforming growth factor-β receptors. J Biol Chem 269: 22868–22874

    PubMed  CAS  Google Scholar 

  31. Yamashita H, ten Dijke P, Franzén P, Miyazono K, Heldin C-H (1994) Formation of heterooligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269: 20172–20178

    PubMed  CAS  Google Scholar 

  32. Okadome T, Yamashita H, Franzén P, Morén A, Heldin C-H, Miyazono K (1994) Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J Biol Chem 269: 30753–30756

    PubMed  CAS  Google Scholar 

  33. Vivien D, Attisano L, Wrana JL, Massagué J (1995) Signaling activity of homologous and heterologous transforming growth factor-13 receptor kinase complexes. J Biol Chem 270: 7134–7141

    Article  PubMed  CAS  Google Scholar 

  34. Franzén P, Heldin C-H, Miyazono K (1995) The GS domain of the transforming growth factor-β type I receptor is important in signal transduction. Biochem Biophys Res Commun 207: 682–689

    Article  PubMed  Google Scholar 

  35. Wieser R, Wrana JL, Massagué J (1995) GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14: 2199–2208

    Google Scholar 

  36. Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H (1996) Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J Biol Chem (in press)

    Google Scholar 

  37. Yamashita H, Okadome T, Franzén P, ten Dijke P, Heldin C-H, Miyazono K (1995) A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-β. J Biol Chem 270: 770–774

    Article  PubMed  CAS  Google Scholar 

  38. Moustakas A, Takumi T, Lin HY, Lodish HF (1995) GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor β and activinA. J Biol Chem 270: 765–769

    Article  PubMed  CAS  Google Scholar 

  39. Cârcamo J, Weis FMB, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 14: 3810–3821

    PubMed  Google Scholar 

  40. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin C-H, Miyazono K (1995) Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130: 217–226

    Article  PubMed  CAS  Google Scholar 

  41. Wang T, Donahoe PK, Zervos AS (1994) Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265: 674–676

    Article  PubMed  CAS  Google Scholar 

  42. Kawabata M, Imamura T, Miyazono K, Engel ME, Moses HL (1995) Interaction of the TGFβ type I receptor with farnesyl-protein transferase-a. J Biol Chem (in press)

    Google Scholar 

  43. Chen R-H, Miettinen PJ, Maruoka EM, Choy L, Derynck R (1995) A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377: 548–552

    Article  PubMed  CAS  Google Scholar 

  44. Chen R-H, Moses HL, Maruoka EM, Derynck R, Kawabata M (1995) Phosphorylationdependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-1 receptors. J Biol Chem 270: 12235–12241

    Article  PubMed  CAS  Google Scholar 

  45. Kawabata M, Chytil A, Moses HL (1995) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-13 receptor. J Biol Chem 270: 5625–5630

    Article  PubMed  CAS  Google Scholar 

  46. Yamada N, Kato M, Yamashita H, Nistér M, Miyazono K, Heldin C-H, Funa K (1995) Enhanced expression of transforming growth factor-13 and its type I and type II receptors in human glioblastoma tissues. Int J Cancer 62: 386–392

    Article  PubMed  CAS  Google Scholar 

  47. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA ‘81: 6002–6006

    Article  PubMed  CAS  Google Scholar 

  48. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB (1994) Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivitiy to TGFβ. Proc Natl Acad Sci USA 91: 8772–8776

    Article  PubMed  CAS  Google Scholar 

  49. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV (1995) Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338

    Article  PubMed  CAS  Google Scholar 

  50. Lu S-L, Akiyama Y, Nagasaki H, Saitoh K, Yuasa Y (1995) Mutations of the transforming growth factor-13 type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452–457

    Article  PubMed  CAS  Google Scholar 

  51. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M (1995) Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982–3987

    PubMed  CAS  Google Scholar 

  52. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV, Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044–22049

    Article  PubMed  CAS  Google Scholar 

  53. Higgins DG, Sharp PM (1989) Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 5: 151–153

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Tokyo

About this paper

Cite this paper

Miyazono, K. (1996). TGF-β Receptors and Signal Transduction. In: Ikehara, S., Takaku, F., Good, R.A. (eds) Bone Marrow Transplantation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68320-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68320-9_15

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68322-3

  • Online ISBN: 978-4-431-68320-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics